Loading clinical trials...
Loading clinical trials...
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
Conditions
Interventions
Syn-One Test
Locations
8
United States
MD First Research
Chandler, Arizona, United States
Banner Health
Phoenix, Arizona, United States
CND Life Sciences
Scottsdale, Arizona, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Stanford Neuroscience Health Center
Palo Alto, California, United States
University of Kentucky
Lexington, Kentucky, United States
Start Date
September 15, 2022
Primary Completion Date
December 17, 2025
Completion Date
December 31, 2025
Last Updated
January 15, 2025
Lead Sponsor
CND Life Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions